hesperidin has been researched along with Liver Failure, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, J; Shi, Q; Song, E; Song, X; Song, Y; Su, C; Xia, X | 1 |
| Bai, X; Buist-Homan, M; Cai, B; Cheng, H; Faber, KN; Jiang, J; Li, L; Luo, X; Moshage, H; Shen, D; Shi, G; Yang, P; Zhou, Q | 1 |
2 other study(ies) available for hesperidin and Liver Failure, Acute
| Article | Year |
|---|---|
Neohesperidin dihydrochalcone down-regulates MyD88-dependent and -independent signaling by inhibiting endotoxin-induced trafficking of TLR4 to lipid rafts.
Topics: Animals; Antioxidants; Blotting, Western; Chalcones; Disease Models, Animal; Down-Regulation; Electrophoretic Mobility Shift Assay; Endotoxins; Flow Cytometry; Fluorescent Antibody Technique; Hesperidin; Immunohistochemistry; Liver Failure, Acute; Membrane Microdomains; Mice; Myeloid Differentiation Factor 88; Protein Transport; RNA, Small Interfering; Signal Transduction; Sweetening Agents; Toll-Like Receptor 4; Transfection | 2015 |
The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro.
Topics: Animals; Biological Products; Concanavalin A; Dose-Response Relationship, Drug; Galactosamine; Hesperidin; In Vitro Techniques; Lipopolysaccharides; Liver Failure, Acute; Male; Protective Agents; Rats; Rats, Wistar | 2017 |